The U.S. Trustee, the bankruptcy arm of the Justice Department, will appoint one or more committees to represent the interests of creditors and stockholders in working with the company to develop a plan of reorganization to get out of debt.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
Soliris is the most striking example of a recent, controversial trend toward highly priced medications, often to treat relatively rare conditions. The University of British Columbiaâs health-policy centre has a conference on the topic planned for next month â called âSticker Shock.â.